Follow-up study for Ro/SSA and La/SSB antibodies
Part of Immune system & allergy clinical trials.
This study follows people who have tested positive for Ro/SSA or La/SSB antibodies (proteins linked to certain autoimmune conditions). It also includes a control group of people without these antibodies or any rheumatologic disease. The goal is to learn more about long-term health patterns.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You can read and understand Swedish.
- You must be able to consent for yourself.
- You have no major infection or severe illness that would make participation unsafe.
- You either have tested positive for Ro/SSA or La/SSB antibodies, or you have no rheumatologic disease and no such antibodies.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This research study collects samples and information from people with rheumatoid arthritis, lupus, or scleroderma, plus healthy volunteers, to better understand how the immune system works in these conditions. By comparing these groups, researchers hope to find new ways to treat and manage autoimmune diseases.
This study looks at an immune reaction (called anti-Ro/SSA IgE) to see how active primary Sjögren’s disease is. It may help doctors better understand what’s driving symptoms and activity levels over time.
This study looks at whether the level of a specific antibody (anti-Ro52) in your blood can predict how Sjögren's syndrome will progress. If you have Sjögren's and have had this blood test, the study may help doctors better understand your condition and tailor your care.
This study follows different groups of people—from those at high risk of developing rheumatoid arthritis to those recently diagnosed—to learn more about the disease. By joining, you help researchers understand who gets RA and why, which may lead to earlier detection and better care.
This study follows adults with systemic scleroderma (also called scleroderma) to better understand the condition over time. You may be included if you meet specific diagnosis and blood-test requirements and can give informed consent.
This study follows people with rheumatoid arthritis, lupus, scleroderma, or a muscle disease called autoimmune myositis. It aims to collect health data and samples to better understand these conditions and improve future treatments.
Hear when a new Autoantibodies trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.